Efficacy and safety of herbal formulation rich in standardized fenugreek seed extract as add-on supplementation in patients with type 2 diabetes mellitus on sulfonylurea therapy: A 12-week, randomized, double-blind, placebo-controlled, multi-center study

AmitD Kandhare; Nadeem Rais; Nivedita Moulick; Alaka Deshpande; Prasad Thakurdesai; Sunil Bhaskaran

doi:10.4103/pm.pm_260_18

Efficacy and safety of herbal formulation rich in standardized fenugreek seed extract as add-on supplementation in patients with type 2 diabetes mellitus on sulfonylurea therapy: A 12-week, randomized, double-blind, placebo-controlled, multi-center study

Pharmacognosy Magazine ◽

10.4103/pm.pm_260_18 ◽

2018 ◽

Vol 14 (57) ◽

pp. 393 ◽

Cited By ~ 5

Author(s):

AmitD Kandhare ◽

Nadeem Rais ◽

Nivedita Moulick ◽

Alaka Deshpande ◽

Prasad Thakurdesai ◽

...

Keyword(s):

Diabetes Mellitus ◽

Seed Extract ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Fenugreek Seed ◽

Herbal Formulation ◽

Multi Center Study ◽

Center Study

Download Full-text

Add-on therapy of herbal formulation rich in standardized fenugreek seed extract in type 2 diabetes mellitus patients with insulin therapy: An efficacy and safety study

Asian Pacific Journal of Tropical Biomedicine ◽

10.4103/2221-1691.242288 ◽

2018 ◽

Vol 8 (9) ◽

pp. 446 ◽

Cited By ~ 3

Author(s):

Amit Kandhare ◽

Uday Phadke ◽

Abhay Mane ◽

Prasad Thakurdesai ◽

Sunil Bhaskaran

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Therapy ◽

Seed Extract ◽

Efficacy And Safety ◽

Safety Study ◽

Fenugreek Seed ◽

Herbal Formulation

Download Full-text

Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12631 ◽

2016 ◽

Vol 18 (5) ◽

pp. 528-532 ◽

Cited By ~ 12

Author(s):

S. Hong ◽

C.-Y. Park ◽

K. A. Han ◽

C. H. Chung ◽

B. J. Ku ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong

Journal of Diabetes ◽

10.1111/1753-0407.12425 ◽

2016 ◽

Vol 9 (4) ◽

pp. 386-395 ◽

Cited By ~ 10

Author(s):

Changyu Pan ◽

Ping Han ◽

Qiuhe Ji ◽

Chengjiang Li ◽

Juming Lu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Hong Kong ◽

Mainland China ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12047 ◽

2013 ◽

Vol 15 (5) ◽

pp. 432-440 ◽

Cited By ~ 90

Author(s):

K. Kaku ◽

S. Inoue ◽

O. Matsuoka ◽

A. Kiyosue ◽

H. Azuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients with Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism ◽

10.31031/gjem.2018.02.000543 ◽

2018 ◽

Vol 2 (4) ◽

Author(s):

Davis Townsend

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled

Diabetes Obesity and Metabolism ◽

10.1111/dom.12382 ◽

2014 ◽

Vol 16 (12) ◽

pp. 1257-1264 ◽

Cited By ~ 62

Author(s):

J. Reusch ◽

M. W. Stewart ◽

C. M. Perkins ◽

D. T. Cirkel ◽

J. Ye ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12898 ◽

2017 ◽

Vol 19 (6) ◽

pp. 874-882 ◽

Cited By ~ 28

Author(s):

Takashi Kadowaki ◽

Nobuya Inagaki ◽

Kazuoki Kondo ◽

Kenichi Nishimura ◽

Genki Kaneko ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of linagliptin as add‐on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14231 ◽

2020 ◽

Author(s):

Wenying Yang ◽

Xiangjin Xu ◽

Tao Lei ◽

Jianhua Ma ◽

Ling Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Chinese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

ENGAGE — A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in adults with Gaucher disease type 1: Results after 18months

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2014.12.179 ◽

2015 ◽

Vol 114 (2) ◽

pp. S81-S82 ◽

Cited By ~ 7

Author(s):

Pramod Mistry ◽

Dominick J. Amato ◽

Majed Dasouki ◽

Seymour Packman ◽

Gregory M. Pastores ◽

...

Keyword(s):

Gaucher Disease ◽

Disease Type ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Gaucher Disease Type 1 ◽

Multi Center Study ◽

Center Study

Download Full-text

Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2017.1359259 ◽

2017 ◽

Vol 18 (13) ◽

pp. 1291-1300 ◽

Cited By ~ 16

Author(s):

Takashi Kadowaki ◽

Kazuoki Kondo ◽

Noriyuki Sasaki ◽

Kyoko Miyayama ◽

Shoko Yokota ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo

Download Full-text